Literature DB >> 17414431

Histopathology of anti-p200 pemphigoid.

Christian Rose1, Wolfgang Weyers, Natalja Denisjuk, Uwe Hillen, Detlef Zillikens, Iakov Shimanovich.   

Abstract

Anti-p200 pemphigoid is an autoimmune subepidermal blistering disease characterized by circulating and tissue-bound antibodies against a 200-kd glycoprotein (p200) of the human dermis. We reviewed 10 lesional biopsies from seven patients with anti-p200 pemphigoid in an attempt to define typical histopathologic features of this disease. All biopsy specimens showed subepidermal blistering and a moderate to dense inflammatory infiltrate in the upper dermis. Immunohistochemical analysis localized type IV collagen to the dermal side of the blister, suggesting that split formation occurred within the lamina lucida of the cutaneous basement membrane. The inflammatory infiltrate was composed almost exclusively of neutrophils in six biopsies and contained a mixture of neutrophils and eosinophils in the remaining four. In three specimens, microabscess formation in the papillary dermis adjacent to the blister cavity was noted. Neutrophilic and eosinophilic spongiosis was found in five and three biopsies, respectively. We conclude that histopathology of anti-p200 pemphigoid is characterized by subepidermal blistering and a superficial inflammatory infiltrate, which is usually dominated by neutrophils but occasionally contains significant numbers of eosinophils. While this microscopic picture mimics that of linear IgA disease, dermatitis herpetiformis, or bullous pemphigoid, it should also alert a histopathologist to the possibility of anti-p200 pemphigoid and prompt immunofluorescence and immunoblotting studies for definite diagnosis or exclusion of this autoimmune subepidermal blistering disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17414431     DOI: 10.1097/DAD.0b013e31803326e6

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  8 in total

Review 1.  Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.

Authors:  Kyle T Amber; Dedee F Murrell; Enno Schmidt; Pascal Joly; Luca Borradori
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

2.  [Anti-p200 pemphigoid: clinical, diagnostic and therapeutic aspects].

Authors:  Katharina Antonia Drerup; Ulrike Wehkamp
Journal:  Hautarzt       Date:  2020-02       Impact factor: 0.751

3.  When Bullous Pemphigoid Is Not Bullous Pemphigoid: The Importance of Going Beyond Direct Immunofluorescence.

Authors:  Christina R Hopkins; Vicky Ren; Raminder Grover; Clay Cockerell; Sylvia Hsu
Journal:  Cureus       Date:  2022-02-14

4.  Pathology of spontaneous and immunotherapy-induced tumor regression in a murine model of melanoma.

Authors:  Kim R M Blenman; Jake Wang; Shawn Cowper; Marcus Bosenberg
Journal:  Pigment Cell Melanoma Res       Date:  2019-02-27       Impact factor: 4.693

5.  Anti-p200 pemphigoid (anti-laminin-γ1 pemphigoid) demonstrating pathergy.

Authors:  Morgan McCarty; Deltef Zillikens; David Fivenson
Journal:  Int J Womens Dermatol       Date:  2015-11-03

Review 6.  Oral Lesions in Autoimmune Bullous Diseases: An Overview of Clinical Characteristics and Diagnostic Algorithm.

Authors:  Hanan Rashid; Aniek Lamberts; Gilles F H Diercks; Hendri H Pas; Joost M Meijer; Maria C Bolling; Barbara Horváth
Journal:  Am J Clin Dermatol       Date:  2019-12       Impact factor: 7.403

7.  Anti-p200 Pemphigoid: A Systematic Review.

Authors:  Khalaf Kridin; A Razzaque Ahmed
Journal:  Front Immunol       Date:  2019-10-22       Impact factor: 7.561

8.  Coexistence of Anti-p200 Pemphigoid and Psoriasis: A Systematic Review.

Authors:  Ying-Han Xie; Si-Hang Wang; Si-Zhe Li; Ya-Gang Zuo
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.